Deal of the Year: The Idenix Settlement

Like so many successes, it started with a failure.

In May 1998, Emory researcher and Professor of Pediatrics Raymond Schinazi was a founder of Emory biotech start-up Pharmasset and Idenix Pharmaceuticals, and was working with these companies on an HIV drug sublicensed from Pharmasset to Idenix that, despite a $5 million investment, hadn’t worked out. . ... more

 

   
  What's New...
 
Technology Transfer Tools ... more

Progesterone Phase III Trials ... more

Emory Starts Drug Discovery Center ... more

Sound Science - Todd Sherer, Director ... more

Trail by Fire: New Antibody Method Gets Big Test ... more

H1N1 Research ... more

OTT Annual Celebration ... more
   
    Gateway to Discovery, Innovation, and Products.